ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. has announced the composition of its Board of Directors, which includes three Executive Directors, one Non-executive Director, and three Independent Non-executive Directors. The company also detailed the membership of its three Board committees: Audit, Remuneration, and Nomination, each led by different chairmen and composed of various members of the Board.
For further insights into HK:1541 stock, check out TipRanks’ Stock Analysis page.